Selected Start-Ups Founded in 1999 (9/99)
Executive Summary
{In Vivo} summarizes the technologies of several medical companies founded within the last year. eBioinformatics Inc. has opened shop to sell low-cost, easy to use bioinformatics resources and tools via the Internet. Lipoxen Ltd. is entering the drug delivery market. Med-i-nets.com is preparing for the launch of a palm-sized point-of-care electronic prescription pad that allows doctors to check for drug interactions and insurance formulary coverage. Proteome Systems Ltd. was founded by the group that created the National Australizan Proteome facility at Macquarie University. Triad Biotechnology Inc. hopes to accelerate the drug discovery process through the use of its NMR-guided technology.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.